Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sachs, S.
Right arrow Articles by Bilfinger, T. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sachs, S.
Right arrow Articles by Bilfinger, T. V.
(Chest. 2005;128:698-703.)
© 2005 American College of Chest Physicians

The Impact of Positron Emission Tomography on Clinical Decision Making in a University-Based Multidisciplinary Lung Cancer Practice*

Sharona Sachs, MD and Thomas V. Bilfinger, MD, ScD, FCCP

* From the Department of Medicine, Division of Pulmonary and Critical Care Medicine (Dr. Sachs), and the Department of Surgery, Division of Cardiothoracic Surgery (Dr. Bilfinger), Stony Brook University School of Medicine, Stony Brook, NY.

Correspondence to: Sharona Sachs, MD, T17, 040, Health Sciences Center, Stony Brook University School of Medicine, Stony Brook, NY 11794-8172; e-mail: ssachs{at}mail.som.sunysb.edu

Introduction: Positron emission tomography (PET) scanning has gained increasing application as a diagnostic and staging tool in the evaluation of lung cancer. Although PET scanning has been demonstrated to be a cost-effective adjunct to lung cancer diagnosis, its global impact on clinical decision making has not been assessed.

Study objectives: To evaluate the impact of the systematic use of PET scanning on clinical decision making.

Design: Retrospective study.

Setting: A university-based multidisciplinary lung cancer practice.

Patients: All patients undergoing diagnostic or staging PET scans from December 31, 2000, to December 31, 2002.

Interventions: None.

Measurements and results: One hundred ninety-eight patients underwent PET for diagnosis (161 patients) or staging (37 patients). PET scan results and clinical outcomes were retrospectively reviewed to determine the frequency with which PET scan findings (1) upstaged patients, (2) downstaged patients, (3) changed the diagnostic workup, (4) altered therapy, (5) resulted in a significant additional diagnosis, and (6) triggered evaluations that ultimately proved fruitless. PET upstaged 32 of 198 patients (16.2%) and downstaged 12 patients (6.1%), facilitating curative resection in 4 patients. Overall, PET scan findings changed the stage in 44 patients (22.2%). PET scan findings changed diagnostic management in 105 of 198 patients (53%), among whom biopsy was deferred in 65 patients (61.9%) and was triggered or guided in 40 patients (38.1%). PET scan findings altered treatment decisions in 38 patients (19.2%), leading to neoadjuvant therapy in 6 patients and resection in 5 patients, and forestalling noncurative thoracotomy in 6 patients. PET scan findings prompted or redirected chemotherapy or radiotherapy in the remainder of the patients. Overall, PET scan findings changed management in 143 patients (72.2%). PET scan findings triggered additional diagnostic testing in 32 patients (16.2%), resulting in no new diagnosis in 16 patients (50%) and a critical change in management in 7 patients (21.9%). PET scan findings were solely responsible for a significant non-lung cancer diagnosis in eight patients (4%).

Conclusions: Systematically applied PET scanning has a significant impact on patient management, altering diagnostic or therapeutic interventions in 72.2% of patients, changing staging in 22.2% of patients, and identifying serious unsuspected diagnoses in 4.0% of patients, with potentially life-saving consequences in 2.0%.Key Words: diagnosis; lung neoplasms; positron emission tomography




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
C. Nwogu, G. Fischer, D. Tan, M. Glinianski, D. Lamonica, and T. Demmy
Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer
Ann. Thorac. Surg., November 1, 2006; 82(5): 1815 - 1820.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. A. Heresi, P. J. Mazzone, and J. K. Stoller
Impact of positron emission tomography on clinical decision making.
Chest, July 1, 2006; 130(1): 300 - 301.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.